M. Goycochea-Robles

Pioglitazone improves the cardiovascular profile in patients with uncomplicated systemic lupus erythematosus: a double-blind randomized clinical trial

J. Mas-Oliva, E. Jorge-Galarza, R. Posadas-Sánchez, 2012, Lupus.

, erythematosus : a double-blind randomized clinical trial Pioglitazone improves the cardiovascular profile in patients with uncomplicated systemic lupus

J. Mas-Oliva, E. Jorge-Galarza, R. Posadas-Sánchez, 2011 .

Validity of the COPCORD Core Questionnaire as a Classification Tool for Rheumatic Diseases

I. Peláez-Ballestas, R. Burgos-Vargas, M. Goycochea-Robles, 2011, The Journal of Rheumatology. Supplement.

A 26 week randomised, double blind, placebo controlled exploratory study of sulfasalazine in juvenile onset spondyloarthropathies

R. Burgos-Vargas, J. Vázquez-Mellado, C. Pacheco-Tena, 2002, Annals of the rheumatic diseases.

Validation of a Spanish version of the Childhood Health Assessment Questionnaire.

R. Burgos-Vargas, J. Garduño-Espinosa, M. Goycochea-Robles, 1997, The Journal of rheumatology.

Successful treatment of pure red cell aplasia associated with systemic lupus erythematosus with cyclosporin A.

R. Burgos-Vargas, M. Goycochea-Robles, J. Cazarín-Barrientos, 2000, Rheumatology.

Organ Damage and Quality of Life in Antiphospholipid Syndrome

P. Alba, J. Gómez-Puerta, M. Amigo, 2016, Current Rheumatology Reports.